JP2016536348A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536348A5
JP2016536348A5 JP2016545243A JP2016545243A JP2016536348A5 JP 2016536348 A5 JP2016536348 A5 JP 2016536348A5 JP 2016545243 A JP2016545243 A JP 2016545243A JP 2016545243 A JP2016545243 A JP 2016545243A JP 2016536348 A5 JP2016536348 A5 JP 2016536348A5
Authority
JP
Japan
Prior art keywords
pyrrol
octahydrocyclopenta
hydroxy
benzyl
rac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016545243A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536348A (ja
JP6546596B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057800 external-priority patent/WO2015048507A1/en
Publication of JP2016536348A publication Critical patent/JP2016536348A/ja
Publication of JP2016536348A5 publication Critical patent/JP2016536348A5/ja
Application granted granted Critical
Publication of JP6546596B2 publication Critical patent/JP6546596B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016545243A 2013-09-26 2014-09-26 Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子 Active JP6546596B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361883050P 2013-09-26 2013-09-26
US61/883,050 2013-09-26
PCT/US2014/057800 WO2015048507A1 (en) 2013-09-26 2014-09-26 Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b

Publications (3)

Publication Number Publication Date
JP2016536348A JP2016536348A (ja) 2016-11-24
JP2016536348A5 true JP2016536348A5 (enExample) 2017-11-24
JP6546596B2 JP6546596B2 (ja) 2019-07-17

Family

ID=52744524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016545243A Active JP6546596B2 (ja) 2013-09-26 2014-09-26 Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子

Country Status (9)

Country Link
US (4) US9540324B2 (enExample)
EP (2) EP3461827B1 (enExample)
JP (1) JP6546596B2 (enExample)
CN (1) CN105916843B (enExample)
AR (1) AR097794A1 (enExample)
ES (2) ES2707739T3 (enExample)
TW (1) TW201605791A (enExample)
UY (1) UY35750A (enExample)
WO (1) WO2015048507A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9540324B2 (en) 2013-09-26 2017-01-10 Luc Therapeutics, Inc. Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
JO3579B1 (ar) 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
ES2821896T3 (es) * 2015-08-05 2021-04-28 Indivior Uk Ltd Antagonistas del receptor de dopamina D3 que tienen una unidad estructural biciclo
WO2018232158A1 (en) * 2017-06-15 2018-12-20 Belite Bio, Inc. Methods of treating metabolic diseases with fused bicyclic pyrroles
US11452881B2 (en) 2019-01-03 2022-09-27 Avive Solutions, Inc. Defibrillator communications architecture
TW202237103A (zh) * 2020-12-04 2022-10-01 瑞士商諾華公司 用於治療抑鬱症的nr2b-nmda受體nam之劑量方案
EP4313042A4 (en) * 2021-03-26 2025-01-15 Novartis AG NEW CYCLOPENTA[C PYRROL NEGATIVE ALLOSTERIC MODULATORS OF NR2B
TW202304885A (zh) * 2021-03-26 2023-02-01 瑞士商諾華公司 新穎的NR2B之環戊烷并[c]吡咯負性異位調節劑

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532243A (en) 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
US5262564A (en) 1992-10-30 1993-11-16 Octamer, Inc. Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
MXPA03008109A (es) * 2001-03-07 2003-12-12 Pfizer Prod Inc Moduladores de la actividad de receptores de quimiocinas.
DE60231608D1 (de) 2001-04-19 2009-04-30 Eisai R&D Man Co Ltd Cyclische amidinderivate
AU2005219438B2 (en) 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
BRPI0511982A (pt) * 2004-06-09 2008-01-22 Hoffmann La Roche compostos antiviróticos heterocìclicos
US20070270417A1 (en) 2004-07-22 2007-11-22 Glaxo Group Limited Antibacterial Agents
EP1874318A2 (en) 2005-04-19 2008-01-09 Merck & Co., Inc. N-alkyl-azacycloalkyl nmda/nr2b antagonists
EP1849772A1 (en) 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
US8299113B2 (en) 2006-04-28 2012-10-30 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
CN101230058A (zh) * 2007-01-23 2008-07-30 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
TW200845977A (en) 2007-03-30 2008-12-01 Targacept Inc Sub-type selective azabicycloalkane derivatives
JP2011500727A (ja) 2007-10-22 2011-01-06 シェーリング コーポレイション Gpr119の活性のモジュレーターとしての二環式ヘテロ環誘導体およびその使用
CA2712352C (en) 2008-01-23 2016-05-10 Jiangsu Hansoh Pharmaceutical Co., Ltd. Dicycloazaalkane derivates, preparation processes and medical uses thereof
US8691865B2 (en) 2008-11-26 2014-04-08 Abbvie Inc. Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
AU2009324479A1 (en) 2008-12-12 2011-06-30 Vanderbilt Universtiy 3.3.0 bicyclic GlyT1 inhibitors and methods of making and using same
FR2945534B1 (fr) * 2009-05-12 2012-11-16 Sanofi Aventis DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2945533B1 (fr) 2009-05-12 2011-05-27 Sanofi Aventis Derives de cyclopenta°c!pyrrolyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
MX2012007935A (es) 2010-01-07 2012-08-15 Du Pont Compuestos heterociclicos fungicidas.
US8796470B2 (en) 2010-05-25 2014-08-05 Abbvie Inc. Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
US8501768B2 (en) 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
EP2721029B1 (en) 2011-06-16 2018-07-18 Merck Sharp & Dohme Corp. Imidazopyridin-2-one derivatives
EP2739617A4 (en) 2011-07-27 2015-01-28 Nanjing Allgen Pharma Co Ltd SPIROCYCLIC MOLECULES AS PROTEIN KINASE INHIBITORS
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
WO2013091539A1 (zh) 2011-12-21 2013-06-27 江苏恒瑞医药股份有限公司 吡咯并六元杂芳环类衍生物、其制备方法及其在医药上的应用
RS59512B1 (sr) 2012-09-25 2019-12-31 Hoffmann La Roche Derivati heksahidropirolo[3,4−c]pirola i srodna jedinjenja kao inhibitori autotaksina (atx) i kao inhibitori proizvodnje lizofosfatidne kiseline (lpa) za lečenje npr. bubrežnih bolesti
AR095079A1 (es) * 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
US9540324B2 (en) 2013-09-26 2017-01-10 Luc Therapeutics, Inc. Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
CN106103446B (zh) 2014-03-26 2019-07-30 豪夫迈·罗氏有限公司 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物

Similar Documents

Publication Publication Date Title
JP2016536348A5 (enExample)
JP3930560B2 (ja) 炎症の処置のための1,2−置換イミダゾリル化合物
RU2452738C2 (ru) Соединения, модулирующие активность c-fms и/или c-kit, и их применения
RU2492167C2 (ru) Производные аминотриазола в качестве агонистов alх
JP2015520764A5 (enExample)
JP2018535999A5 (enExample)
JP2018530591A5 (enExample)
JP2014528450A5 (enExample)
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
CA2478156A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2010533158A5 (enExample)
JP2010508338A5 (enExample)
JP2005511543A5 (enExample)
RU2008141509A (ru) Mglur5 модуляторы 1
JP2016512515A5 (enExample)
JP2020506946A5 (enExample)
NZ609955A (en) Sgc stimulators
JP2019537571A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
RU2011134868A (ru) N-замещенные насыщенные гетероциклические сульфоновые соединения с активностью агонистов рецептора св2
JP2017537948A5 (enExample)
JP2019518036A5 (enExample)
RU2010146485A (ru) Новые лиганды эстрогеновых рецепторов
JP2009504792A5 (enExample)
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1